CYCN Projected Dividend Yield
Cyclerion Therapeutics Inc ( NASDAQ : CYCN )Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for serious diseases. Co.'s portfolio includes soluble guanylate cyclase (sGC) stimulators that modulate a key node in a fundamental signaling network in both the central nervous system (CNS) and the periphery. The nitric oxide (NO) sGC cyclic guanosine monophosphate (cGMP) signaling pathway is a fundamental mechanism that controls key aspects of physiology throughout the body. The NO-sGC-cGMP pathway regulates biological functions including mitochondrial function, neuronal function, inflammation, and hemodynamics. 20 YEAR PERFORMANCE RESULTS |
CYCN Dividend History Detail CYCN Dividend News CYCN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |